PREMIER Biosoft International releases PrimerPlex, a tool for designing custom oligos for the simultaneous analysis of up to 100 different nucleic acid sequences. The product is designed for use with Luminex 100, Luminex 200 and Bio-Plex 200 suspension array systems. The detection is based on Luminex's xMAP® technology.

Palo Alto, California – November 14, 2007, PREMIER Biosoft International today announced the release of their new product, PrimerPlex. PrimerPlex designs custom oligos for rapid and high-throughput detection of nucleic acid sequences for Luminex 100, Luminex 200 and Bio-Plex Suspension Array systems. The systems are based on Luminex's liquid bead array based xMAP® technology. The major advantage of xMAP® technology is its ability to detect up to 100 sequences in a single reaction.

PrimerPlex will enable users to design custom Capture Probes for the bead arrays based detection system and Allele Specific Primer Extension (ASPE) assays. PrimerPlex is a valuable tool for researchers working on drug screening and validation, gene expression profiling, genotyping, autoimmune and infectious diseases.

"PrimerPlex is the only software product available that supports oligo design for the technology offered by Luminex Corporation. PrimerPlex is a powerful tool for suspension array users to design highly specific and successful multiplex assays." commented Kay Brown, V.P. Business Development and Marketing.

For details, please visit: http://www.premierbiosoft.com/primerplex/index.html.

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.premierbiosoft.com.

Contact:
Arun Apte
PREMIER Biosoft International
Ph: 650-856-2703